Episódios

  • CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy
    Sep 19 2024

    Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss.

    Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496

    Exibir mais Exibir menos
    2 minutos
  • Improving Clinical Documentation Efficiency with AI
    Sep 18 2024

    Dr. Irfan Sheikh explores a newly released NeuroByte episode, providing an insightful overview of how AI technologies, including ambient intelligence, can streamline documentation processes and enhance the efficiency of clinical practices.

    Show references:

    https://learning.aan.com/courses/74256

    Exibir mais Exibir menos
    2 minutos
  • Monoclonal Antibody to PACAP for Migraine Prevention - Part 2
    Sep 17 2024

    In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention.

    Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577

    Exibir mais Exibir menos
    4 minutos
  • Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene
    Sep 16 2024

    Dr. Rae Bacharach discusses the Neurology Today article, "Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene?" by Gina Shaw, available in the September 5th issue of Neurology Today or at neurologytoday.com.

    Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09050/large_study_finds_covid_vaccination_does_not.3.aspx

    Exibir mais Exibir menos
    3 minutos
  • Monoclonal Antibody to PACAP for Migraine Prevention - Part 1
    Sep 13 2024

    In the first installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina explore the biology of PACAP, its significance in relation to migraines, and its potential as a novel therapeutic approach.

    Show reference:

    https://www.nejm.org/doi/full/10.1056/NEJMoa2314577

    Exibir mais Exibir menos
    5 minutos
  • Association of Extent of TSS With Cerebral Glymphatic Clearance in Patients With IIH
    Sep 12 2024

    Dr. Amy Gelfand and Dr. Matthew Bender discuss the possible association between glymphatic outflow and extent of TSS in patients with IIH.

    Show reference:

    https://www.neurology.org/doi/10.1212/WNL.0000000000209529

    Exibir mais Exibir menos
    2 minutos
  • Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
    Sep 11 2024

    Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org.

    Show reference:

    https://www.neurology.org/doi/10.1212/WNL.0000000000209745

    Exibir mais Exibir menos
    2 minutos
  • Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses
    Sep 10 2024

    Dr. Rae Bacharach discusses the Neurology Today article, "Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses" by Susan FitzGerald, available in the September 5th issue of Neurology Today or at neurologytoday.com.

    Show reference:

    https://journals.lww.com/neurotodayonline/fulltext/2024/09050/large_study_finds_covid_vaccination_does_not.3.aspx

    Exibir mais Exibir menos
    3 minutos